Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review.
Journal
PharmacoEconomics
ISSN: 1179-2027
Titre abrégé: Pharmacoeconomics
Pays: New Zealand
ID NLM: 9212404
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
accepted:
15
09
2022
pubmed:
15
12
2022
medline:
17
2
2023
entrez:
14
12
2022
Statut:
ppublish
Résumé
The objective of our study was to review, synthesize, and grade published evidence of caregiver burden of spinal muscular atrophy (SMA), a rare autosomal-recessive neuromuscular disease. We searched Embase and PubMed for full-text articles published from inception up until 28 February, 2022, reporting results from studies of caregiver burden (i.e., negative aspects of providing informal care) in SMA. Two investigators independently screened article titles and abstracts for eligibility, reviewed full-text versions of selected records, extracted the data, and assessed risk of bias using the Newcastle-Ottawa Scale. The evidence was synthesized to answer the following questions: (1) In which geographical settings have the caregiver burden of SMA been studied? (2) What aspects of the caregiver burden of SMA have been investigated? (3) What instruments have been used to measure the caregiver burden of SMA? (4) What is known of the caregiver burden of SMA? (5) How is the caregiver burden of SMA impacted by available disease-modifying drugs? We identified 15 publications, covering samples from a total of ten countries (i.e., Australia, Canada, China, France, Germany, Romania, Spain, Turkey, the UK, and the USA), reporting estimates of caregiver burden derived using data recorded via surveys or interviews. The most common instruments used to measure caregiver burden were the Zarit Caregiver Burden Interview, the EQ-5D-5L, and the PedsQL Family Impact Model. Caregiving in SMA was found to be associated with reduced health-related quality of life, impaired family function, depression and anxiety, strain, and stress, as well as a substantial impact on work life and productivity. Evidence of the impact of disease-modifying drugs on caregiver burden in SMA was scarce. Caregivers to patients with SMA were found to be subject to a significant burden, including impaired health-related quality of life, reduced work ability and productivity, and financial stress, and many devote a substantial proportion of their time to provide informal care. Yet, the current body of literature is relatively scarce and more research is needed to better understand the clinical implications of informal caregiving in SMA and the relationship between caregiver burden and SMA types, as well as the impact of new disease-modifying treatments. Our synthesis will be helpful in informing clinical and social support programs (e.g., the routine screening of depression among caregivers, as well as financial support schemes to help manage the long-term day-to-day care) directed towards families caring for patients with SMA.
Identifiants
pubmed: 36515815
doi: 10.1007/s40273-022-01197-9
pii: 10.1007/s40273-022-01197-9
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
275-293Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy. Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103–15. https://doi.org/10.1016/j.nmd.2017.11.005 .
doi: 10.1016/j.nmd.2017.11.005
pubmed: 29290580
Schorling DC, Pechmann A, Kirschner J. Advances in treatment of spinal muscular atrophy: new phenotypes, new challenges, new implications for care. J Neuromuscul Dis. 2020;7(1):1–13. https://doi.org/10.3233/JND-190424 (PMID: 31707373; PMCID: PMC7029319).
doi: 10.3233/JND-190424
pubmed: 31707373
pmcid: 7029319
Finkel RS, McDermott MP, Kaufmann P, Darras BT, Chung WK, Sproule DM, et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology. 2014;83(9):810–7. https://doi.org/10.1212/WNL.0000000000000741 (Epub 2014 Jul 30. PMID: 25080519; PMCID: PMC4155049).
doi: 10.1212/WNL.0000000000000741
pubmed: 25080519
pmcid: 4155049
Kirschner J. Postnatal gene therapy for neuromuscular diseases: opportunities and limitations. J Perinat Med. 2021;49(8):1011–5. https://doi.org/10.1515/jpm-2021-0435 (PMID: 34499826).
doi: 10.1515/jpm-2021-0435
pubmed: 34499826
Dangouloff T, Vrščaj E, Servais L, Osredkar D, SMA NBS World Study Group. Newborn screening programs for spinal muscular atrophy worldwide: where we stand and where to go. Neuromuscul Disord. 2021;31(6):574–82. https://doi.org/10.1016/j.nmd.2021.03.007 (Epub 2021 Apr 7. PMID: 33985857).
doi: 10.1016/j.nmd.2021.03.007
pubmed: 33985857
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71.PMID:33782057;PMCID:PMC8005924 .
doi: 10.1136/bmj.n71.PMID:33782057;PMCID:PMC8005924
pubmed: 33782057
pmcid: 8005924
Morningstar Inc. Morningstar indexes. Available from: https://www.morningstar.com . Accessed 15 Mar 2022.
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. OHRI. 2000. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 21 Sep 2022.
Landfeldt E, Pechmann A, McMillan HJ, Lochmüller H, Sejersen T. Costs of illness of spinal muscular atrophy: a systematic review. Appl Health Econ Health Policy. 2021;19(4):501–20. https://doi.org/10.1007/s40258-020-00624-2 (Epub 2021 Feb 12. PMID: 33576939; PMCID: PMC8270802).
doi: 10.1007/s40258-020-00624-2
pubmed: 33576939
pmcid: 8270802
Aranda-Reneo I, Peña-Longobardo LM, Oliva-Moreno J, Litzkendorf S, Durand-Zaleski I, Tizzano EF, et al. The burden of spinal muscular atrophy on informal caregivers. Int J Environ Res Public Health. 2020;17(23):8989. https://doi.org/10.3390/ijerph17238989 (PMID: 33276656; PMCID: PMC7730048).
doi: 10.3390/ijerph17238989
pubmed: 33276656
pmcid: 7730048
Belter L, Cruz R, Jarecki J. Quality of life data for individuals affected by spinal muscular atrophy: a baseline dataset from the Cure SMA Community Update Survey. Orphanet J Rare Dis. 2020;15(1):217. https://doi.org/10.1186/s13023-020-01498-2 (PMID: 32838797; PMCID: PMC7447573).
doi: 10.1186/s13023-020-01498-2
pubmed: 32838797
pmcid: 7447573
Chambers GM, Settumba SN, Carey KA, Cairns A, Menezes MP, Ryan M, et al. Prenusinersen economic and health-related quality of life burden of spinal muscular atrophy. Neurology. 2020;95(1):e1–10. https://doi.org/10.1212/WNL.0000000000009715 (Epub 2020 Jun 8 PMID: 32513788).
doi: 10.1212/WNL.0000000000009715
pubmed: 32513788
Cremers CH, Fischer MJ, Kruitwagen-van Reenen ET, Wadman RI, Vervoordeldonk JJ, Verhoef M, et al. Participation and mental well-being of mothers of home-living patients with spinal muscular atrophy. Neuromuscul Disord. 2019;29(4):321–9. https://doi.org/10.1016/j.nmd.2019.02.011 (Epub 2019 Mar 2 PMID: 30954388).
doi: 10.1016/j.nmd.2019.02.011
pubmed: 30954388
Acar AE, Karadağ Saygı E, İmamoğlu S, Öztürk G, Ünver O, Ergenekon P, et al. The burden of primary caregivers of spinal muscular atrophy patients and their needs. Turk Arch Pediatr. 2021;56(4):366–73. https://doi.org/10.5152/TurkArchPediatr.2021.20117 (PMID: 35005732; PMCID: PMC8655964).
doi: 10.5152/TurkArchPediatr.2021.20117
Farrar MA, Carey KA, Paguinto SG, Chambers G, Kasparian NA. Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives. BMJ Open. 2018;8(5): e020907. https://doi.org/10.1136/bmjopen-2017-020907 (PMID: 29794098; PMCID: PMC5988080).
doi: 10.1136/bmjopen-2017-020907
pubmed: 29794098
pmcid: 5988080
Klug C, Schreiber-Katz O, Thiele S, Schorling E, Zowe J, Reilich P, et al. Disease burden of spinal muscular atrophy in Germany. Orphanet J Rare Dis. 2016;11(1):58. https://doi.org/10.1186/s13023-016-0424-0 (PMID: 27145956; PMCID: PMC4857429).
doi: 10.1186/s13023-016-0424-0
pubmed: 27145956
pmcid: 4857429
López-Bastida J, Peña-Longobardo LM, Aranda-Reneo I, Tizzano E, Sefton M, Oliva-Moreno J. Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain. Orphanet J Rare Dis. 2017;12(1):141. https://doi.org/10.1186/s13023-017-0695-0 (PMID: 28821278; PMCID: PMC5563035).
doi: 10.1186/s13023-017-0695-0
pubmed: 28821278
pmcid: 5563035
McMillan HJ, Gerber B, Cowling T, Khuu W, Mayer M, Wu JW, et al. Burden of spinal muscular atrophy (SMA) on patients and caregivers in Canada. J Neuromuscul Dis. 2021;8(4):553–68. https://doi.org/10.3233/JND-200610 (PMID: 33749617; PMCID: PMC8385498).
doi: 10.3233/JND-200610
pubmed: 33749617
pmcid: 8385498
Morcov MV, Padure L, Morcov CG, Onose G. Findings regarding emotion regulation strategies and quality of life’s domains in families having children with spinal muscular atrophy. J Med Life. 2021;14(3):390–6. https://doi.org/10.25122/jml-2021-0098 (PMID: 34377206; PMCID: PMC8321616).
doi: 10.25122/jml-2021-0098
pubmed: 34377206
pmcid: 8321616
Peña-Longobardo LM, Aranda-Reneo I, Oliva-Moreno J, Litzkendorf S, Durand-Zaleski I, Tizzano E, et al. The economic impact and health-related quality of life of spinal muscular atrophy: an analysis across Europe. Int J Environ Res Public Health. 2020;17(16):5640. https://doi.org/10.3390/ijerph17165640 (PMID: 32764338; PMCID: PMC7459726).
doi: 10.3390/ijerph17165640
pubmed: 32764338
pmcid: 7459726
von Gontard A, Backes M, Laufersweiler-Plass C, Wendland C, Lehmkuhl G, Zerres K, et al. Psychopathology and familial stress- comparison of boys with Fragile X syndrome and spinal muscular atrophy. J Child Psychol Psychiatry. 2002;43(7):949–57. https://doi.org/10.1111/1469-7610.00098 (PMID: 12405482).
doi: 10.1111/1469-7610.00098
Weaver MS, Yuroff A, Sund S, Hetzel S, Halanski MA. Quality of life outcomes according to differential nusinersen exposure in pediatric spinal muscular atrophy. Children (Basel). 2021;8(7):604. https://doi.org/10.3390/children8070604 (PMID: 34356583; PMCID: PMC8305818).
doi: 10.3390/children8070604
pubmed: 34356583
pmcid: 8305818
Yao M, Ma Y, Qian R, Xia Y, Yuan C, Bai G, et al. Quality of life of children with spinal muscular atrophy and their caregivers from the perspective of caregivers: a Chinese cross-sectional study. Orphanet J Rare Dis. 2021;16(1):7. https://doi.org/10.1186/s13023-020-01638-8 (PMID: 33407670; PMCID: PMC7789582).
doi: 10.1186/s13023-020-01638-8
pubmed: 33407670
pmcid: 7789582
Yao M, Xia Y, Feng Y, Ma Y, Hong Y, Zhang Y, et al. Anxiety and depression in school-age patients with spinal muscular atrophy: a cross-sectional study. Orphanet J Rare Dis. 2021;16(1):385. https://doi.org/10.1186/s13023-021-02008-8 (PMID: 34503559; PMCID: PMC8427846).
doi: 10.1186/s13023-021-02008-8
pubmed: 34503559
pmcid: 8427846
Bladen CL, Thompson R, Jackson JM, Garland C, Wegel C, Ambrosini A, et al. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol. 2014;261(1):152–63. https://doi.org/10.1007/s00415-013-7154-1 (Epub 2013 Oct 27 PMID: 24162038).
doi: 10.1007/s00415-013-7154-1
pubmed: 24162038
Janssen MF, Szende A, Cabases J, Ramos-Goñi JM, Vilagut G, König HH. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ. 2019;20(2):205–16. https://doi.org/10.1007/s10198-018-0955-5 (Epub 2018 Feb 14. PMID: 29445941; PMCID: PMC6438939).
doi: 10.1007/s10198-018-0955-5
pubmed: 29445941
Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14(6):1523–32. https://doi.org/10.1007/s11136-004-7713-0 (PMID: 16110932).
doi: 10.1007/s11136-004-7713-0
pubmed: 16110932
Sullivan PW, Ghushchyan V. Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410–20. https://doi.org/10.1177/0272989X06290495 (PMID: 16855129; PMCID: PMC2634296).
doi: 10.1177/0272989X06290495
pubmed: 16855129
pmcid: 2634296
Boyer F, Drame M, Morrone I, Novella JL. Factors relating to carer burden for families of persons with muscular dystrophy. J Rehabil Med. 2006;38(5):309–15. https://doi.org/10.1080/16501970600731578 (PMID: 16931461).
doi: 10.1080/16501970600731578
pubmed: 16931461
Landfeldt E, Lindgren P, Bell CF, Guglieri M, Straub V, Lochmüller H, et al. Quantifying the burden of caregiving in Duchenne muscular dystrophy. J Neurol. 2016;263(5):906–15. https://doi.org/10.1007/s00415-016-8080-9 (Epub 2016 Mar 10. PMID: 26964543; PMCID: PMC4859858).
doi: 10.1007/s00415-016-8080-9
pubmed: 26964543
pmcid: 4859858
Srivastava G, Tripathi RK, Tiwari SC, Singh B, Tripathi SM. Caregiver burden and quality of life of key caregivers of patients with dementia. Indian J Psychol Med. 2016;38(2):133–6. https://doi.org/10.4103/0253-7176.178779 (PMID: 27114625; PMCID: PMC4820552).
doi: 10.4103/0253-7176.178779
pubmed: 27114625
pmcid: 4820552
Schischlevskij P, Cordts I, Günther R, Stolte B, Zeller D, Schröter C, et al. Informal caregiving in amyotrophic lateral sclerosis (ALS): a high caregiver burden and drastic consequences on caregivers’ lives. Brain Sci. 2021;11(6):748. https://doi.org/10.3390/brainsci11060748 (PMID: 34200087; PMCID: PMC8228206).
doi: 10.3390/brainsci11060748
pubmed: 34200087
pmcid: 8228206
Macchi ZA, Koljack CE, Miyasaki JM, Katz M, Galifianakis N, Prizer LP, et al. Patient and caregiver characteristics associated with caregiver burden in Parkinson’s disease: a palliative care approach. Ann Palliat Med. 2020;9(Suppl. 1):S24-33. https://doi.org/10.21037/apm.2019.10.01 (Epub 2019 Nov 14 PMID: 31735048).
doi: 10.21037/apm.2019.10.01
pubmed: 31735048
Adeosun II. Correlates of caregiver burden among family members of patients with schizophrenia in Lagos, Nigeria. Schizophr Res Treat. 2013. https://doi.org/10.1155/2013/353809 (Epub 2013 Oct 3. PMID: 24222848; PMCID: PMC3816073).
doi: 10.1155/2013/353809
Hagell P, Alvariza A, Westergren A, Årestedt K. Assessment of burden among family caregivers of people with Parkinson’s disease using the Zarit Burden Interview. J Pain Symptom Manag. 2017;53(2):272–8. https://doi.org/10.1016/j.jpainsymman.2016.09.007 (Epub 2016 Nov 1 PMID: 27810571).
doi: 10.1016/j.jpainsymman.2016.09.007
Al-Rawashdeh SY, Lennie TA, Chung ML. Psychometrics of the Zarit Burden Interview in caregivers of patients with heart failure. J Cardiovasc Nurs. 2016;31(6):E21–8. https://doi.org/10.1097/JCN.0000000000000348 (PMID: 27617563; PMCID: PMC5069100).
doi: 10.1097/JCN.0000000000000348
pubmed: 27617563
pmcid: 5069100
Landfeldt E, Mayhew A, Straub V, Bushby K, Lochmüller H, Lindgren P. Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysis. Disabil Rehabil. 2019;41(8):966–73. https://doi.org/10.1080/09638288.2017.1416501 (Epub 2017 Dec 18 PMID: 29254382).
doi: 10.1080/09638288.2017.1416501
pubmed: 29254382
Pudelewicz A, Talarska D, Bączyk G. Burden of caregivers of patients with Alzheimer’s disease. Scand J Caring Sci. 2019;33(2):336–41. https://doi.org/10.1111/scs.12626 (Epub 2018 Oct 31 PMID: 30378698).
doi: 10.1111/scs.12626
pubmed: 30378698
Kanters TA, Brugts JJ, Manintveld OC, Versteegh MM. Burden of providing informal care for patients with atrial fibrillation. Value Health. 2021;24(2):236–43. https://doi.org/10.1016/j.jval.2020.09.011 (Epub 2020 Nov 3 PMID: 33518030).
doi: 10.1016/j.jval.2020.09.011
pubmed: 33518030
Bayen E, Papeix C, Pradat-Diehl P, Lubetzki C, Joël ME. Patterns of objective and subjective burden of informal caregivers in multiple sclerosis. Behav Neurol. 2015. https://doi.org/10.1155/2015/648415 (Epub 2015 May 20. PMID: 26078487; PMCID: PMC4452831).
doi: 10.1155/2015/648415
pubmed: 26078487
pmcid: 4452831
Galvin M, Carney S, Corr B, Mays I, Pender N, Hardiman O. Needs of informal caregivers across the caregiving course in amyotrophic lateral sclerosis: a qualitative analysis. BMJ Open. 2018;8(1): e018721. https://doi.org/10.1136/bmjopen-2017-018721 (PMID: 29374665; PMCID: PMC5829772).
doi: 10.1136/bmjopen-2017-018721
pubmed: 29374665
pmcid: 5829772
Rattinger GB, Schwartz S, Mullins CD, Corcoran C, Zuckerman IH, Sanders C, et al. Dementia severity and the longitudinal costs of informal care in the Cache County population. Alzheimers Dement. 2015;11(8):946–54. https://doi.org/10.1016/j.jalz.2014.11.004 (Epub 2015 Jan 19. PMID: 25614127; PMCID: PMC4506892).
doi: 10.1016/j.jalz.2014.11.004
pubmed: 25614127
pmcid: 4506892
Rodríguez AA, Martínez Ó, Amayra I, López-Paz JF, Al-Rashaida M, Lázaro E, et al. Diseases costs and impact of the caring role on informal carers of children with neuromuscular disease. Int J Environ Res Public Health. 2021;18(6):2991. https://doi.org/10.3390/ijerph18062991 (PMID: 33803993; PMCID: PMC7999397).
doi: 10.3390/ijerph18062991
pubmed: 33803993
pmcid: 7999397
Aranda-Reneo I, Oliva-Moreno J, Vilaplana-Prieto C, Hidalgo-Vega Á, González-Domínguez A. Informal care of patients with schizophrenia. J Ment Health Policy Econ. 2013;16(3):99–108 (PMID: 24327480).
pubmed: 24327480
Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology. 2014;83(6):529–36. https://doi.org/10.1212/WNL.0000000000000669 (Epub 2014 Jul 2. PMID: 24991029; PMCID: PMC4141999).
doi: 10.1212/WNL.0000000000000669
pubmed: 24991029
pmcid: 4141999
Lee J, Kim SH, Kim Y, Kim YL, Sohn Y. Quality of life of caregivers of individuals with Parkinson’s disease. Rehabil Nurs. 2019;44(6):338–48. https://doi.org/10.1097/rnj.0000000000000158 (PMID: 29864045).
doi: 10.1097/rnj.0000000000000158
pubmed: 29864045
Brehaut JC, Kohen DE, Raina P, Walter SD, Russell DJ, Swinton M, et al. The health of primary caregivers of children with cerebral palsy: how does it compare with that of other Canadian caregivers? Pediatrics. 2004;114(2):e182–91. https://doi.org/10.1542/peds.114.2.e182 (PMID: 15286255).
doi: 10.1542/peds.114.2.e182
pubmed: 15286255
Liu Y, Dokos M, Fauth EB, Lee YG, Zarit SH. Financial strain, employment, and role captivity and overload over time among dementia family caregivers. Gerontologist. 2019;59(5):e512–20. https://doi.org/10.1093/geront/gnz099 (PMID: 31322654; PMCID: PMC6857684).
doi: 10.1093/geront/gnz099
pubmed: 31322654
pmcid: 6857684
De Vivo DC, Bertini E, Swoboda KJ, Hwu WL, Crawford TO, Finkel RS, et al. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the phase 2 NURTURE study. Neuromuscul Disord. 2019;29(11):842–56. https://doi.org/10.1016/j.nmd.2019.09.007 (Epub 2019 Sep 12. PMID: 31704158; PMCID: PMC7127286).
doi: 10.1016/j.nmd.2019.09.007
pubmed: 31704158
pmcid: 7127286
Strauss K, Farrar M, Muntoni F, Saito K, Mendell JR, Servais L, et al. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the phase III SPR1NT trial. Nat Med. 2022;28(7):1381–9. https://doi.org/10.1038/s41591-022-01866-4 (Epub 2022 Jun 17. PMID: 35715566; PMCID: PMC9205281).
doi: 10.1038/s41591-022-01866-4
pubmed: 35715566
pmcid: 9205281
Strauss K, Farrar M, Muntoni F, Saito K, Mendell JR, Servais L, et al. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the phase III SPR1NT trial. Nat Med. 2022;28(7):1390–7. https://doi.org/10.1038/s41591-022-01867-3 (Epub 2022 Jun 17. PMID: 35715567; PMCID: PMC9205287).
doi: 10.1038/s41591-022-01867-3
pubmed: 35715567
pmcid: 9205287
Dangouloff T, Hiligsmann M, Deconinck N, D’Amico A, Seferian AM, Boemer F, et al. Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening. Dev Med Child Neurol. 2022. https://doi.org/10.1111/dmcn.15286 (Epub ahead of print. PMID: 35673937).
doi: 10.1111/dmcn.15286
pubmed: 35673937
Landfeldt E. The cost-effectiveness of newborn screening for spinal muscular atrophy. Dev Med Child Neurol. 2022. https://doi.org/10.1111/dmcn.15314 (Epub ahead of print. PMID: 35698880).
doi: 10.1111/dmcn.15314
pubmed: 35698880
Magliano L, D’Angelo MG, Vita G, Pane M, D’Amico U, Balottin U, et al. Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study. Acta Myolog. 2014;33(3):136–43 (PMID: 25873782; PMCID: PMC4369844).